MassChallenge Startups Create Impact

2,458

Startups Accelerated

$6.2B

Funding Raised

$3B

Revenue Generated

157,000+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
MSL Pharma (Met Syn Lysine Ltd).
MSL Pharma (Met Syn Lysine Ltd).

50% of overweight & obese individuals suffer from Metabolic Syndrome in which there is a chronic elevation of blood Insulin levels, which in turn increases Insulin Resistance, causing an increase in appetite and over-eating, thus creating a vicious cycle, causing MI & Strokes.
We will cut off this vicious cycle by inhibiting Insulin secretion using a Somatostatin analogue, reverse Metabolic Syndrome, lower body weight & prevent pre-diabetic patients from developing type 2 diabetes.
A cyclic oral Somatostatin analogue to reverse Metabolic Syndrome will lower weight, blood sugar, blood pressure & balance blood lipids

Connect with MSL Pharma (Met Syn Lysine Ltd).

2020

2020 Finalist Israel

Sub industry

Therapeutics (Pharma / Biotech)

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.